BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

980 related articles for article (PubMed ID: 25318641)

  • 1. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of a clinical decision rule-based alert system for drug dose adjustment in patients with renal failure intended to improve pharmacists' analysis of medication orders in hospitals.
    Boussadi A; Caruba T; Karras A; Berdot S; Degoulet P; Durieux P; Sabatier B
    Int J Med Inform; 2013 Oct; 82(10):964-72. PubMed ID: 23831104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach to optimize electronic health record medication alerts in a health system.
    Bhakta SB; Colavecchia AC; Haines L; Varkey D; Garey KW
    Am J Health Syst Pharm; 2019 Apr; 76(8):530-536. PubMed ID: 31361861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
    Van De Sijpe G; Quintens C; Walgraeve K; Van Laer E; Penny J; De Vlieger G; Schrijvers R; De Munter P; Foulon V; Casteels M; Van der Linden L; Spriet I
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):48. PubMed ID: 35193547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
    Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased appropriateness of customized alert acknowledgement reasons for overridden medication alerts in a computerized provider order entry system.
    Dekarske BM; Zimmerman CR; Chang R; Grant PJ; Chaffee BW
    Int J Med Inform; 2015 Dec; 84(12):1085-93. PubMed ID: 26428286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience.
    Topaz M; Seger DL; Slight SP; Goss F; Lai K; Wickner PG; Blumenthal K; Dhopeshwarkar N; Chang F; Bates DW; Zhou L
    J Am Med Inform Assoc; 2016 May; 23(3):601-8. PubMed ID: 26578227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Investigation of Drug-Drug Interaction Alert Overrides at a Pediatric Hospital.
    Humphrey K; Jorina M; Harper M; Dodson B; Kim SY; Ozonoff A
    Hosp Pediatr; 2018 May; 8(5):293-299. PubMed ID: 29700011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of clinical support warnings through recategorization of severity levels.
    Parke C; Santiago E; Zussy B; Klipa D
    Am J Health Syst Pharm; 2015 Jan; 72(2):144-8. PubMed ID: 25550138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription order risk factors for pediatric dosing alerts.
    Stultz JS; Porter K; Nahata MC
    Int J Med Inform; 2015 Feb; 84(2):134-40. PubMed ID: 25466381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practitioners' views on computerized drug-drug interaction alerts in the VA system.
    Ko Y; Abarca J; Malone DC; Dare DC; Geraets D; Houranieh A; Jones WN; Nichol WP; Schepers GP; Wilhardt M
    J Am Med Inform Assoc; 2007; 14(1):56-64. PubMed ID: 17068346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences among admitting departments in alerts and alert overrides for drug-drug interaction.
    Ahn EK; Kam HJ; Park DK; Jung EY; Lee Y; Park RW
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):390-7. PubMed ID: 24677664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.